Kidney Trouble Doubles Rash Risk During Pancreatic Cancer Drug Combo, Study Finds
A retrospective study of 313 patients found that baseline renal impairment doubled the risk of rash during gemcitabine plus nab-paclitaxel ...
A retrospective study of 313 patients found that baseline renal impairment doubled the risk of rash during gemcitabine plus nab-paclitaxel ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.